Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | intermediate filament protein | 0.0028 | 0.0161 | 0.0358 |
Schistosoma mansoni | lamin | 0.0028 | 0.0161 | 0.0305 |
Onchocerca volvulus | 0.0051 | 0.0431 | 0.0509 | |
Schistosoma mansoni | lozenge | 0.0058 | 0.0525 | 0.1422 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0061 | 0.5 |
Loa Loa (eye worm) | macrophage migration inhibitory factor 2 | 0.0152 | 0.1663 | 0.3037 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0061 | 0.5 |
Schistosoma mansoni | survival motor neuron protein | 0.0051 | 0.0431 | 0.1134 |
Echinococcus multilocularis | lamin dm0 | 0.0028 | 0.0161 | 0.01 |
Schistosoma mansoni | hypothetical protein | 0.0175 | 0.1943 | 0.5773 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0061 | 0.5 |
Leishmania major | macrophage migration inhibitory factor-like protein | 0.0356 | 0.4147 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0061 | 0.5 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.002 | 0.0061 | 0.5 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.002 | 0.0061 | 0.0112 |
Brugia malayi | Bm-MIF-1, identical | 0.0356 | 0.4147 | 0.7575 |
Brugia malayi | hypothetical protein | 0.0465 | 0.5475 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0061 | 0.5 |
Loa Loa (eye worm) | glutaminase | 0.0288 | 0.3321 | 0.6066 |
Entamoeba histolytica | macrophage migration inhibitory factor-like protein | 0.0356 | 0.4147 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0061 | 0.5 |
Leishmania major | macrophage migration inhibitory factor-like protein | 0.0356 | 0.4147 | 1 |
Plasmodium vivax | macrophage migration inhibitory factor, putative | 0.0356 | 0.4147 | 0.5 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.002 | 0.0061 | 0.0112 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0061 | 0.5 |
Mycobacterium ulcerans | glutaminase | 0.0288 | 0.3321 | 1 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0248 | 0.2837 | 0.2792 |
Schistosoma mansoni | intermediate filament proteins | 0.0028 | 0.0161 | 0.0305 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0356 | 0.4147 | 1 |
Trichomonas vaginalis | macrophage migration inhibitory factor, mif, putative | 0.0356 | 0.4147 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0175 | 0.1943 | 0.5773 |
Trypanosoma brucei | unspecified product | 0.002 | 0.0061 | 0.5 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.002 | 0.0061 | 0.0112 |
Loa Loa (eye worm) | macrophage migration inhibitory factor | 0.0356 | 0.4147 | 0.7575 |
Echinococcus granulosus | geminin | 0.0175 | 0.1943 | 0.6781 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0028 | 0.0161 | 0.0293 |
Trichomonas vaginalis | glutaminase, putative | 0.0288 | 0.3321 | 0.7978 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.002 | 0.0061 | 0.5 |
Schistosoma mansoni | glutaminase | 0.0288 | 0.3321 | 1 |
Echinococcus multilocularis | musashi | 0.0028 | 0.0161 | 0.01 |
Echinococcus multilocularis | Protein lozenge | 0.0058 | 0.0525 | 0.0466 |
Loa Loa (eye worm) | runx1 | 0.0058 | 0.0525 | 0.0958 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0061 | 0.5 |
Brugia malayi | hypothetical protein | 0.0248 | 0.2837 | 0.5181 |
Loa Loa (eye worm) | macrophage migration inhibitory factor 2 | 0.0152 | 0.1663 | 0.3037 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0161 | 0.0293 |
Plasmodium falciparum | macrophage migration inhibitory factor | 0.0356 | 0.4147 | 0.5 |
Echinococcus multilocularis | geminin | 0.0175 | 0.1943 | 0.1893 |
Loa Loa (eye worm) | intermediate filament protein | 0.0028 | 0.0161 | 0.0293 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0061 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0061 | 0.5 |
Brugia malayi | intermediate filament protein | 0.0028 | 0.0161 | 0.0293 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0051 | 0.0431 | 0.0787 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0028 | 0.0161 | 0.0293 |
Toxoplasma gondii | macrophage migration inhibitory factor, putative | 0.0356 | 0.4147 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0154 | 0.0282 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0248 | 0.2837 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.0288 | 0.3321 | 0.6066 |
Echinococcus granulosus | lamin | 0.0028 | 0.0161 | 0.0358 |
Loa Loa (eye worm) | hypothetical protein | 0.0465 | 0.5475 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0061 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0061 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.002 | 0.0061 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0061 | 0.0112 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0061 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0051 | 0.0431 | 0.1134 |
Echinococcus multilocularis | lamin | 0.0028 | 0.0161 | 0.01 |
Brugia malayi | glutaminase DH11.1 | 0.0288 | 0.3321 | 0.6066 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0061 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0465 | 0.5475 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0248 | 0.2837 | 0.5181 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.002 | 0.0061 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0061 | 0.5 |
Onchocerca volvulus | 0.0465 | 0.5475 | 1 | |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0061 | 0.5 |
Giardia lamblia | Macrophage migration inhibitory factor | 0.0356 | 0.4147 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0061 | 0.5 |
Schistosoma mansoni | lamin | 0.0028 | 0.0161 | 0.0305 |
Echinococcus granulosus | lamin dm0 | 0.0028 | 0.0161 | 0.0358 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.